Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Moderna Stock Will Jump in Value On Completing Covid-19 Vaccine Tests

By Mark R. Hake, CFA
Moderna is looking to get its vaccine emergency use approval. Moderna stock is worth at least one-third more from its Covid-19 vaccine.

7 Clean Energy Stocks To Watch Ahead Of The U.S. Election

By Ian Cooper, InvestorPlace Contributor
On speculation that Joe Biden could win the U.S. presidential election, clean energy stocks are pushing to higher highs.

Will Exxon Stock Hit New Lows on Earnings, Dividend Affirmation?

By Bret Kenwell, InvestorPlace Contributor
Exxon Mobil reported mixed earnings and will maintain its dividend even with the yield north of 11%. Let's look at XOM stock more closely.

How Novavax Has a 2-Pronged Approach to Vaccine Sales

By Chris Lau, InvestorPlace Contributor
NVAX stock is faring worse than its peers as investors await more positive clinical data from the company.

RUN Will Benefit From Sunrun’s Position As a Leading Solar Company

By Tezcan Gecgil, InvestorPlace Contributor
Sunrun's recent acquisition of Vivint Solar will likely mean further synergies, which should support RUN stock.

Lordstown Motors: Can GM’s Old Plant Beat It?

By Dana Blankenhorn, InvestorPlace Contributor
Lordstown Motors has a plan to take on Tesla in electric truck fleet sales. Like other start-ups it is scooping up capital that in previous years might have gone to General Motors.

Chesapeake Energy Must Be Praying for a Trump Victory

By Chris Markoch, InvestorPlace Contributor
Chesapeake Energy stock is worthless coming out of bankruptcy and the company's narrow path to relevance will be complicated by a Biden win.

With the Credibility Suck Impacting Nokia, You Should Stay Away From the Stock

By Josh Enomoto, InvestorPlace Contributor
After a terrible showing in the third quarter, Nokia stock took a deserved beating. But the scope of the devastation suggests that there’s more at play here than just bad ink.

Amid An Oil Industry Slide, BP Stands for Bad Play

By Lou Carlozo, InvestorPlace Contributor
The novel coronavirus pandemic is wreaking havoc on the energy sector. Demand may never recover and that means bad news for BP stock.

Why Pivotal Investment Stock Looks Appealing for Certain Investors

By Larry Ramer, InvestorPlace Contributor
XL Fleet has many positive characteristics, including a high-value service and a strong management team. Longer-term, risk-tolerant investors should buy PIC stock.

HEXO Reverse Stock Split 2020: 12 Things for HEXO Stock Investors to Know

By William White, InvestorPlace Writer
Hexo (HEXO), a cannabis company based out of Canada, has announced plans for a reverse stock split to regain NYSE compliance.

AbbVie News: 5 Things for ABBV Investors to Know About Q3

By William White, InvestorPlace Writer
AbbVie (ABBV) news for Friday includes results from the biopharmaceutical company's earnings report for the third quarter of 2020.

Root Insurance IPO Poised to Disrupt the Insurance Market

By David Moadel, InvestorPlace Contributor
It's not the first neo-insurance IPO of 2020, but the Root Insurance IPO may still be a worthy bet on a unique insure-tech start-up.

Weak Earnings Imply Blue Apron Botched Its Covid-19 Tailwind

By Luke Lango, InvestorPlace Senior Investment Analyst
Blue Apron was once one of the market's best turnaround candidates; so much for that bull thesis on APRN stock.

Streaming News: What We Know About the $1 Billion Sony – Crunchyroll Deal

By William White, InvestorPlace Writer
Leading streaming news for Friday is a deal reportedly taking place that will have Sony (SNE) buying Crunchyroll for $1 billion.

EQ Stock: 6 Things to Know about Biotech Company Equillium

By William White, InvestorPlace Writer
Equillium (EQ) stock is seeing gains on Friday after getting the go-ahead from the FDA for a drug trial treating the coronavirus.

BioLineRX News: Why BLRX Stock Is Skyrocketing Today

By Nick Clarkson, Web Editor
BLRX stock is blasting off on Friday morning after the company reported strong results from a Phase-3 trial for one of its cancer treatments.

Hertz Global News: 13 Things to Know as HTZ Stock Gets Kicked Off NYSE

By William White, InvestorPlace Writer
Hertz Global (HTZGQ) news for Friday includes the company being delisted from the New York Stock Exchange as it goes through bankruptcy.

SPAC News: 9 Things to Know About EV Maker Fisker Stock

By William White, InvestorPlace Writer
Fisker (FSR) news for Friday includes it completing its deal with special purpose acquisition company (SPAC) Spartan Energy Acquisition.
Load More Articles